Dirofilaria repens is a nematode affecting domestic and wild canids, transmitted by several species of mosquitoes. It usually causes a non-pathogenic subcutaneous infection in dogs and is the principal agent of human dirofilariosis in Europe. In the last decades, Dirofilaria repens has increased in prevalence in areas where it has already been reported and its distribution range has expanded into new areas of Europe, representing a paradigmatic example of an emergent pathogen².
In the ophthalmic literature, the number of cases of human dirofilariasis reported in the last 50 years has gradually increased. Global warming in particular, has created conditions favouring the development of infective larvae in mosquitoes, and facilitated the recent spread of Dirofilaria spp. to Central Europe. Dirofilaria repens is now endemic in many countries in the region (Poland, Ukraine, Germany, Austria, Hungary, Netherlands), and is currently considered to be one of the fast spreading zoonoses in Central, Eastern and Northern Europe³,⁴.
The first empirical evidence of Swiss spreading of Dirofilaria infections was in a dog from southern Switzerland in 1998. A few years later, another two positive dogs were found in Canton Ticino in 2001⁵׳⁶.
Dirofilaria is a common parasite of dogs, who constitute the main source of infection. Humans are accidental hosts and many infected subjects are asymptomatic. Transmission occurs through the bite of zooanthropophilic types of Aedes, Culex, or Anopheles mosquitoes carrying infective larvae acquired from the microfilariae-rich blood of animal hosts parasitized with either deep-seated or subcutaneous worms of the Dirofilaria species. In humans, the nematode causes a subcutaneous or superficially located inflammatory reaction that traps it within a nodule, where it may survive for many years⁷. Such lesions are always associated with moderate to severe inflammation. However, it may also present as a noninflammatory lid tumor.
Dirofilaria is well known to affect the eye and the adnexa⁸. The infection may be periocular, subconjunctival, or intraocular. The first case of ocular dirofilariasis was reported in 1885 by Addario⁹, an Italian ophthalmologist. He found a Dirofilaria worm in the conjunctiva of a Sicilian woman and called it Dirofilaria conjunctiva. The largest series of cases–six with periocular involvement by Dirofilaria was described by Font in 1980¹⁰. More recently reports included one involving the lateral rectus muscle of a 20-year-old man¹¹, conjunctival tissue of a 27-year-old female¹² and a 35-year-old male¹³ and a superficial orbital dirofilariasis in a 24-year-old female¹⁴. It was recently reported a case of ocular dirofilariosis in a 76- year-old patient in the course of cataract surgery in Bulgaria caused by gravid female nematode¹⁵ and a case of a 12-year-old patient with a rapid growing deep orbital mass and imaging findings suggestive of Rhabdomyosarcoma that was found to be Dirofilariasis after mass resection¹⁶.
In the literature there are up-to-date 38 reported cases of ocular/orbital/eyelid dirofilariosis. The majority of articles were case reports of up to 3 patients, with the exception of Dzamic et al.¹⁷ who presented 19 cases of human dirofilariasis in Serbia, both ocular and subcutaneous and Kalogeropoulos et al.¹⁸ who presented 8 cases of ocular dirofilariasis. In published reports of ocular dirofilariasis, most of the cases were located under the conjunctiva (> 60% of all cases) followed by orbital/eyelid dirofilariasis (approximately 25%).
In general, the diagnosis of human dirofilariasis is based on histologic examination. Useful characteristics for differentiating between the different Dirofilaria species, are the size and the features of the body wall, i.e., thickness of the cuticle and its structure, ridges, lateral chords, and number and type of muscle cells¹⁹.
Therapy with systemic antibiotics has proved useless and surgical removal of the worm is the only known treatment. Usually, the clinical symptoms disappear after the parasite is removed and no adjunct therapy is necessary²⁰.